| Symbol | RDY |
|---|---|
| Name | DR REDDYS LABORATORIES LTD |
| Sector | HEALTH CARE |
| Region | Asia |
| Industry | Pharmaceutical Preparations |
| Address | 8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD, None 500-034 |
| Telephone | 91 40 49002900 |
| Fax | — |
| — | |
| Website | https://www.drreddys.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001135951 |
| Description | Headquartered in India, Dr. Reddys Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the companys sales are well dispersed across North America, India, and other emerging markets. Additional info from NASDAQ: |
2026-06-26 15:10
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
Read more
2026-06-13 10:22
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
Read more
2026-05-16 07:18
Dr. Reddys Laboratories Launches its Generic Semaglutide Injection in Canada
Read more
2026-04-29 11:38
Dr. Reddys Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
Read more
2026-04-10 08:39
New Form 3 - DR REDDYS LABORATORIES LTD <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001575872-26-000242 <b>Size:</b> 4 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07475572 | A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-D… | Phase1 | Melanoma | Not_Yet_Recruiting | 2026-06-19 | 2028-04-14 | ClinicalTrials.gov |
| NCT07475572 | A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-D… | Phase1 | Melanoma | Not_Yet_Recruiting | 2026-06-19 | 2028-04-14 | ClinicalTrials.gov |
| NCT06126042 | Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal He… | Phase1 | Rheumatoid Arthritis | Unknown | 2023-10-03 | 2024-07-01 | ClinicalTrials.gov |
| NCT06126042 | Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal He… | Phase1 | Rheumatoid Arthritis | Unknown | 2023-10-03 | 2024-07-01 | ClinicalTrials.gov |
| NCT05200559 | T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent… | Phase1 | Epithelial Ovarian Cancer | Active_Not_Recruiting | 2022-09-30 | 2030-12-31 | ClinicalTrials.gov |
| NCT05200559 | T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent… | Phase1 | Epithelial Ovarian Cancer | Active_Not_Recruiting | 2022-09-30 | 2030-12-31 | ClinicalTrials.gov |
| NCT04885829 | Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers | Phase1 | Rheumatoid Arthritis | Completed | 2021-05-31 | 2023-05-04 | ClinicalTrials.gov |
| NCT04885829 | Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers | Phase1 | Rheumatoid Arthritis | Completed | 2021-05-31 | 2023-05-04 | ClinicalTrials.gov |
| NCT04640233 | Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Ve… | Phase2 | COVID-19 Prevention | Unknown | 2020-11-30 | 2021-09-01 | ClinicalTrials.gov |
| NCT04640233 | Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Ve… | Phase2 | COVID-19 Prevention | Unknown | 2020-11-30 | 2021-09-01 | ClinicalTrials.gov |
| NCT04529499 | Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to… | Phase3 | Covid19 | Terminated | 2020-08-22 | 2021-01-27 | ClinicalTrials.gov |
| NCT04529499 | Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to… | Phase3 | Covid19 | Terminated | 2020-08-22 | 2021-01-27 | ClinicalTrials.gov |
| NCT04268771 | A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products | Phase3 | Rheumatoid Arthritis | Completed | 2020-04-08 | 2022-04-20 | ClinicalTrials.gov |
| NCT04268771 | A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products | Phase3 | Rheumatoid Arthritis | Completed | 2020-04-08 | 2022-04-20 | ClinicalTrials.gov |
| NCT03976102 | Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (… | Phase3 | Follicular Lymphoma | Completed | 2019-05-15 | 2023-02-27 | ClinicalTrials.gov |
| NCT03976102 | Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (… | Phase3 | Follicular Lymphoma | Completed | 2019-05-15 | 2023-02-27 | ClinicalTrials.gov |
| NCT03554772 | Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15 | Phase2 | Acute Pain | Completed | 2018-06-19 | 2018-08-20 | ClinicalTrials.gov |
| NCT03554772 | Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15 | Phase2 | Acute Pain | Completed | 2018-06-19 | 2018-08-20 | ClinicalTrials.gov |
| NCT03472378 | Can DFN-15 Terminate Migraine With Allodynia? | Phase2 | Migraine With Aura | Completed | 2018-05-09 | 2019-04-12 | ClinicalTrials.gov |
| NCT03472378 | Can DFN-15 Terminate Migraine With Allodynia? | Phase2 | Migraine With Aura | Completed | 2018-05-09 | 2019-04-12 | ClinicalTrials.gov |
| NCT03421197 | A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) | Phase2 | Psoriasis | Completed | 2018-01-25 | 2020-03-30 | ClinicalTrials.gov |
| NCT03421197 | A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) | Phase2 | Psoriasis | Completed | 2018-01-25 | 2020-03-30 | ClinicalTrials.gov |
| NCT03599193 | A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderat… | Phase2 | Acne Vulgaris | Completed | 2017-10-04 | 2018-04-30 | ClinicalTrials.gov |
| NCT03599193 | A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderat… | Phase2 | Acne Vulgaris | Completed | 2017-10-04 | 2018-04-30 | ClinicalTrials.gov |
| NCT03340961 | A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-… | Phase2 | Rosacea | Completed | 2017-10-01 | 2019-03-31 | ClinicalTrials.gov |
| NCT03340961 | A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-… | Phase2 | Rosacea | Completed | 2017-10-01 | 2019-03-31 | ClinicalTrials.gov |
| NCT03341910 | A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Loti… | Phase2 | Acne Vulgaris | Completed | 2017-08-21 | 2018-05-18 | ClinicalTrials.gov |
| NCT03341910 | A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Loti… | Phase2 | Acne Vulgaris | Completed | 2017-08-21 | 2018-05-18 | ClinicalTrials.gov |
| NCT03290027 | A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris | Phase3 | Acne Vulgaris | Completed | 2017-07-31 | 2018-04-19 | ClinicalTrials.gov |
| NCT03290027 | A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris | Phase3 | Acne Vulgaris | Completed | 2017-07-31 | 2018-04-19 | ClinicalTrials.gov |
| NCT03292640 | A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vu… | Phase3 | Acne Vulgaris | Completed | 2017-07-06 | 2018-05-14 | ClinicalTrials.gov |
| NCT03292640 | A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vu… | Phase3 | Acne Vulgaris | Completed | 2017-07-06 | 2018-05-14 | ClinicalTrials.gov |
| NCT03282838 | Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on D… | Phase1 | Migraine | Completed | 2017-06-09 | 2018-01-12 | ClinicalTrials.gov |
| NCT03282838 | Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on D… | Phase1 | Migraine | Completed | 2017-06-09 | 2018-01-12 | ClinicalTrials.gov |
| NCT03160807 | Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract… | Phase4 | Urinary Tract Infection | Unknown | 2017-04-15 | 2018-03-01 | ClinicalTrials.gov |
| NCT03160807 | Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract… | Phase4 | Urinary Tract Infection | Unknown | 2017-04-15 | 2018-03-01 | ClinicalTrials.gov |
| NCT03116698 | A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actini… | Phase2 | Actinic Keratosis (AK) | Completed | 2017-02-14 | 2018-07-05 | ClinicalTrials.gov |
| NCT03116698 | A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actini… | Phase2 | Actinic Keratosis (AK) | Completed | 2017-02-14 | 2018-07-05 | ClinicalTrials.gov |
| NCT03009019 | Efficacy, Tolerability, and Safety of DFN-15 | Phase3 | Migraine Headache | Completed | 2016-12-01 | 2019-05-01 | ClinicalTrials.gov |
| NCT03009019 | Efficacy, Tolerability, and Safety of DFN-15 | Phase3 | Migraine Headache | Completed | 2016-12-01 | 2019-05-01 | ClinicalTrials.gov |
| NCT03478436 | Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers | Phase1 | Rosacea | Completed | 2016-07-01 | 2016-10-25 | ClinicalTrials.gov |
| NCT02828241 | A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 | Phase2 | Rosacea | Completed | 2016-07-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT02828241 | A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 | Phase2 | Rosacea | Completed | 2016-07-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT03478436 | Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers | Phase1 | Rosacea | Completed | 2016-07-01 | 2016-10-25 | ClinicalTrials.gov |
| NCT02798419 | Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects… | Phase2 | Common Warts | Completed | 2016-01-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02798419 | Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects… | Phase2 | Common Warts | Completed | 2016-01-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT03702855 | Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2015-12-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT03702855 | Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2015-12-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT03696329 | Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2015-10-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT03696329 | Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2015-10-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02569853 | DFN-11 Injection in Episodic Migraine With or Without Aura | Phase3 | Episodic Migraine | Completed | 2015-09-21 | 2018-02-26 | ClinicalTrials.gov |
| NCT02569853 | DFN-11 Injection in Episodic Migraine With or Without Aura | Phase3 | Episodic Migraine | Completed | 2015-09-21 | 2018-02-26 | ClinicalTrials.gov |
| NCT02571049 | Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalati… | Phase2 | Rapidly Escalating Migraine | Completed | 2015-09-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02571049 | Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalati… | Phase2 | Rapidly Escalating Migraine | Completed | 2015-09-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02583425 | Pilot Study of DFN-11 Injection in Medication Overuse Headache | Phase2 | Medication Overuse Headache | Terminated | 2015-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02572986 | A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% … | Phase3 | Scabies | Completed | 2015-09-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02572986 | A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% … | Phase3 | Scabies | Completed | 2015-09-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02583425 | Pilot Study of DFN-11 Injection in Medication Overuse Headache | Phase2 | Medication Overuse Headache | Terminated | 2015-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02301962 | Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer | Phase4 | Cancer | Unknown | 2015-07-28 | 2022-01-31 | ClinicalTrials.gov |
| NCT02301962 | Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer | Phase4 | Cancer | Unknown | 2015-07-28 | 2022-01-31 | ClinicalTrials.gov |
| NCT03051685 | Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine … | Phase1 | Healthy | Completed | 2015-07-20 | 2015-11-10 | ClinicalTrials.gov |
| NCT03051685 | Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine … | Phase1 | Healthy | Completed | 2015-07-20 | 2015-11-10 | ClinicalTrials.gov |
| NCT02472418 | Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches | Phase2 | Migraine | Completed | 2015-06-05 | 2016-05-05 | ClinicalTrials.gov |
| NCT02472418 | Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches | Phase2 | Migraine | Completed | 2015-06-05 | 2016-05-05 | ClinicalTrials.gov |
| NCT02865161 | Amtolmetin Gaucil in Knee Osteoarthritis | — | Knee Osteoarthritis | Completed | 2015-02-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02865161 | Amtolmetin Gaucil in Knee Osteoarthritis | — | Knee Osteoarthritis | Completed | 2015-02-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT03706300 | Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended … | Phase1 | Healthy | Completed | 2014-12-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT03706300 | Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended … | Phase1 | Healthy | Completed | 2014-12-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02296775 | Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Thre… | Phase1 | Rheumatoid Arthritis | Completed | 2014-11-01 | 2017-10-05 | ClinicalTrials.gov |
| NCT02296775 | Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Thre… | Phase1 | Rheumatoid Arthritis | Completed | 2014-11-01 | 2017-10-05 | ClinicalTrials.gov |
| NCT02279082 | DFN-02 Open Label Safety Study in Patients With Acute Migraine | Phase3 | Acute Migraine | Completed | 2014-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT02712502 | Levofloxacin in Bacterial Rhinosinussitis | — | Rhinosinusitis | Completed | 2014-09-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02712502 | Levofloxacin in Bacterial Rhinosinussitis | — | Rhinosinusitis | Completed | 2014-09-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02279082 | DFN-02 Open Label Safety Study in Patients With Acute Migraine | Phase3 | Acute Migraine | Completed | 2014-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT02260544 | Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | Phase1 | Ovarian Epithelial Cancer Recurrent | Completed | 2014-07-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02260544 | Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | Phase1 | Ovarian Epithelial Cancer Recurrent | Completed | 2014-07-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02173301 | A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-… | Phase2 | Psoriasis | Completed | 2014-06-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02173301 | A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-… | Phase2 | Psoriasis | Completed | 2014-06-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02097485 | Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Tr… | Phase2 | Head Lice Infestation | Completed | 2014-05-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT02097485 | Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Tr… | Phase2 | Head Lice Infestation | Completed | 2014-05-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT02062060 | Study of the Efficacy and Safety of Abametapir Lotion Administered for the Trea… | Phase3 | Head Lice Infestation | Completed | 2014-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02060903 | A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Tr… | Phase3 | Head Lice Infestation | Completed | 2014-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02205320 | A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of … | Phase1 | Pharmacokinetics | Unknown | 2014-02-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02205320 | A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of … | Phase1 | Pharmacokinetics | Unknown | 2014-02-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02062060 | Study of the Efficacy and Safety of Abametapir Lotion Administered for the Trea… | Phase3 | Head Lice Infestation | Completed | 2014-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02060903 | A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Tr… | Phase3 | Head Lice Infestation | Completed | 2014-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02061813 | Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion | Phase1 | Head Lice | Completed | 2014-01-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02061813 | Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion | Phase1 | Head Lice | Completed | 2014-01-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02062073 | Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion | Phase1 | Head Lice | Completed | 2014-01-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT02062073 | Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion | Phase1 | Head Lice | Completed | 2014-01-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT02140073 | Research of Efficient Use of Omeprazole in Combination With Domperidone in Gast… | Phase4 | GERD | Unknown | 2013-12-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT02140073 | Research of Efficient Use of Omeprazole in Combination With Domperidone in Gast… | Phase4 | GERD | Unknown | 2013-12-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01888367 | Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Un… | Phase2 | Surgical Site Infections | Completed | 2013-10-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01888367 | Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Un… | Phase2 | Surgical Site Infections | Completed | 2013-10-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02711943 | Non Interventional Study of Levofloxacin in Chronic Prostatitis | — | Chronic Prostatitis | Completed | 2013-07-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT02711943 | Non Interventional Study of Levofloxacin in Chronic Prostatitis | — | Chronic Prostatitis | Completed | 2013-07-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT02010333 | A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topicall… | Phase2 | Head Lice Infestation | Completed | 2013-04-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02010333 | A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topicall… | Phase2 | Head Lice Infestation | Completed | 2013-04-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01907490 | Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of H… | Phase2 | Head Lice Infestation | Completed | 2013-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01907490 | Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of H… | Phase2 | Head Lice Infestation | Completed | 2013-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT02638831 | Ketorol Gel in Gonarthrosis and Low Back Pain | Phase4 | Gonarthrosis | Completed | 2013-03-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT02638831 | Ketorol Gel in Gonarthrosis and Low Back Pain | Phase4 | Gonarthrosis | Completed | 2013-03-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT02922699 | Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases | Phase4 | GERD | Completed | 2013-01-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT02922699 | Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases | Phase4 | GERD | Completed | 2013-01-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT02322619 | Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2012-11-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT02322619 | Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2012-11-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01674530 | Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Tre… | Phase3 | Chronic Idiopathic Constipation | Completed | 2012-10-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01674530 | Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Tre… | Phase3 | Chronic Idiopathic Constipation | Completed | 2012-10-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01559545 | A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metroni… | Phase2 | Clostridium Difficile Associated Diarrhea | Completed | 2012-03-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01559545 | A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metroni… | Phase2 | Clostridium Difficile Associated Diarrhea | Completed | 2012-03-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01496352 | DFA-02 in Patients Undergoing Colorectal Surgery | Phase1 | Surgical Site Infection | Completed | 2012-02-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01496352 | DFA-02 in Patients Undergoing Colorectal Surgery | Phase1 | Surgical Site Infection | Completed | 2012-02-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01518699 | Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Vo… | Phase1 | Pediculosis | Completed | 2012-01-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01518699 | Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Vo… | Phase1 | Pediculosis | Completed | 2012-01-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT02295046 | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80… | Phase1 | Healthy | Completed | 2011-10-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT02295046 | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80… | Phase1 | Healthy | Completed | 2011-10-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT02292069 | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80… | Phase1 | Healthy | Completed | 2011-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT02292069 | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80… | Phase1 | Healthy | Completed | 2011-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01503424 | Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study | Phase1 | Fed | Completed | 2011-08-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01402024 | Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children a… | Phase3 | Chemotherapy Induced Nausea and Vomiting | Completed | 2011-08-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01402024 | Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children a… | Phase3 | Chemotherapy Induced Nausea and Vomiting | Completed | 2011-08-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01503424 | Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study | Phase1 | Fed | Completed | 2011-08-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01503398 | Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting C… | Phase1 | Fasting | Completed | 2011-08-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01503398 | Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting C… | Phase1 | Fasting | Completed | 2011-08-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT02297854 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fast… | Phase1 | Healthy | Completed | 2011-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT02296723 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed … | Phase1 | Healthy | Completed | 2011-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT02297854 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fast… | Phase1 | Healthy | Completed | 2011-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01388816 | A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein … | Phase2 | Type II Hyperlipidemia | Completed | 2011-07-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01388816 | A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein … | Phase2 | Type II Hyperlipidemia | Completed | 2011-07-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT02296723 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed … | Phase1 | Healthy | Completed | 2011-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01888224 | Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition | Phase1 | Healthy | Completed | 2011-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01888224 | Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition | Phase1 | Healthy | Completed | 2011-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01336647 | An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatme… | Phase2 | Pediculosis | Completed | 2011-04-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01336647 | An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatme… | Phase2 | Pediculosis | Completed | 2011-04-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT02922712 | Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteo… | Phase4 | Knee Osteoarthritis | Completed | 2011-03-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT02922712 | Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteo… | Phase4 | Knee Osteoarthritis | Completed | 2011-03-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01888718 | Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets… | Phase1 | Healthy | Completed | 2011-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01888718 | Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets… | Phase1 | Healthy | Completed | 2011-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01581788 | Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditio… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01691469 | Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition | Phase1 | Healthy | Completed | 2011-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01691456 | Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Cond… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01581775 | Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01581788 | Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditio… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01694797 | Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Co… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01694797 | Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Co… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01691456 | Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Cond… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01691469 | Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition | Phase1 | Healthy | Completed | 2011-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01581775 | Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2011-01-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01673997 | Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting C… | Phase1 | Healthy | Completed | 2010-12-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01673997 | Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting C… | Phase1 | Healthy | Completed | 2010-12-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT02322632 | Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions | Phase1 | Healthy | Completed | 2010-11-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT02322632 | Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions | Phase1 | Healthy | Completed | 2010-11-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01923259 | Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condit… | Phase1 | Healthy | Completed | 2010-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01923558 | Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Co… | Phase1 | Healthy | Completed | 2010-10-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01923259 | Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condit… | Phase1 | Healthy | Completed | 2010-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01923558 | Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Co… | Phase1 | Healthy | Completed | 2010-10-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01888757 | Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition | Phase1 | Healthy | Completed | 2010-09-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01888757 | Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition | Phase1 | Healthy | Completed | 2010-09-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01888263 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Co… | Phase1 | Healthy | Completed | 2010-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01888250 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fastin… | Phase1 | Healthy | Completed | 2010-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01888263 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Co… | Phase1 | Healthy | Completed | 2010-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01888250 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fastin… | Phase1 | Healthy | Completed | 2010-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01888731 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fastin… | Phase1 | Healthy | Completed | 2010-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01888731 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fastin… | Phase1 | Healthy | Completed | 2010-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01057537 | UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events | Phase3 | Cardiovascular Diseases | Completed | 2010-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01566487 | Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condit… | Phase1 | Healthy | Completed | 2010-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01057537 | UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events | Phase3 | Cardiovascular Diseases | Completed | 2010-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01645449 | Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2010-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01566487 | Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condit… | Phase1 | Healthy | Completed | 2010-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01645449 | Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2010-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01674517 | Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under F… | Phase1 | Healthy | Completed | 2010-02-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT01671709 | Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition | Phase1 | Healthy | Completed | 2010-02-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01671722 | Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed Condition | Phase1 | Healthy | Completed | 2010-02-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01671722 | Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed Condition | Phase1 | Healthy | Completed | 2010-02-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01671709 | Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition | Phase1 | Healthy | Completed | 2010-02-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01674517 | Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under F… | Phase1 | Healthy | Completed | 2010-02-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT02296762 | Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition | Phase1 | Healthy | Completed | 2010-02-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT02296762 | Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition | Phase1 | Healthy | Completed | 2010-02-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT02296749 | Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2010-01-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT02296749 | Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2010-01-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT01674504 | Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under F… | Phase1 | Healthy | Completed | 2010-01-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT01674504 | Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under F… | Phase1 | Healthy | Completed | 2010-01-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT01627847 | Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Cond… | Phase1 | Healthy | Completed | 2009-10-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT01504503 | Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Co… | Phase1 | Healthy | Completed | 2009-10-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT01627847 | Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Cond… | Phase1 | Healthy | Completed | 2009-10-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT01627834 | Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting … | Phase1 | Healthy | Completed | 2009-10-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT01627834 | Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting … | Phase1 | Healthy | Completed | 2009-10-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT01504516 | Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condit… | Phase1 | Healthy | Completed | 2009-10-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT01504516 | Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condit… | Phase1 | Healthy | Completed | 2009-10-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT01504503 | Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Co… | Phase1 | Healthy | Completed | 2009-10-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT01645423 | Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2009-08-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT01645423 | Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2009-08-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT01645384 | Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Condi… | Phase1 | Healthy | Completed | 2009-05-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT01645384 | Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Condi… | Phase1 | Healthy | Completed | 2009-05-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT01645410 | Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2009-03-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT01645410 | Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2009-03-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT01513057 | Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditi… | Phase1 | Healthy | Completed | 2009-01-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT01513044 | Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting Con… | Phase1 | Healthy | Completed | 2009-01-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT01513057 | Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditi… | Phase1 | Healthy | Completed | 2009-01-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT01513044 | Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting Con… | Phase1 | Healthy | Completed | 2009-01-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT01270308 | Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions | Phase1 | Healthy | Completed | 2008-12-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT01270308 | Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions | Phase1 | Healthy | Completed | 2008-12-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT01621763 | Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2008-09-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT02322658 | Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2008-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT01627886 | Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Conditi… | Phase1 | Healthy | Completed | 2008-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT01627886 | Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Conditi… | Phase1 | Healthy | Completed | 2008-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT01621763 | Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2008-09-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT02322658 | Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2008-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT01621750 | Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions | Phase1 | Fasting | Completed | 2008-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT01621750 | Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions | Phase1 | Fasting | Completed | 2008-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT02322645 | Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2008-08-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT02322645 | Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2008-08-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT01155947 | Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting C… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT02291341 | Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Con… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT02291341 | Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Con… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT01155960 | Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Condi… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT02291367 | Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fastin… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT01155947 | Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting C… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT02291367 | Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fastin… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT01155960 | Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Condi… | Phase1 | Healthy | Completed | 2008-05-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT01053338 | Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg… | Phase1 | Healthy | Completed | 2008-04-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT01053338 | Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg… | Phase1 | Healthy | Completed | 2008-04-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT01053208 | Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg… | Phase1 | Healthy | Completed | 2008-04-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT01372982 | Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Condi… | Phase1 | Healthy | Completed | 2008-04-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT01372982 | Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Condi… | Phase1 | Healthy | Completed | 2008-04-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT01053208 | Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg… | Phase1 | Healthy | Completed | 2008-04-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT01375452 | Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting C… | Phase1 | Healthy | Completed | 2008-03-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT01375452 | Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting C… | Phase1 | Healthy | Completed | 2008-03-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT01506063 | Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under F… | Phase1 | Healthy | Completed | 2008-01-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01131988 | Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting… | Phase1 | Healthy | Completed | 2008-01-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT01132027 | Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories… | Phase1 | Healthy | Completed | 2008-01-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT01506063 | Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under F… | Phase1 | Healthy | Completed | 2008-01-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01132027 | Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories… | Phase1 | Healthy | Completed | 2008-01-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT01131988 | Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting… | Phase1 | Healthy | Completed | 2008-01-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT01283061 | Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2007-12-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01506076 | Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under F… | Phase1 | Fasting | Completed | 2007-12-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01506076 | Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under F… | Phase1 | Fasting | Completed | 2007-12-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01283061 | Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2007-12-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01283867 | Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Labo… | Phase1 | FED | Completed | 2007-11-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT01283841 | Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Labo… | Phase1 | Fasting | Completed | 2007-11-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT01283841 | Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Labo… | Phase1 | Fasting | Completed | 2007-11-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT01283867 | Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Labo… | Phase1 | FED | Completed | 2007-11-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT01133483 | Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER… | Phase1 | Healthy | Completed | 2007-04-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01133483 | Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER… | Phase1 | Healthy | Completed | 2007-04-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01506011 | Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules… | Phase1 | Fasting | Completed | 2007-03-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01506011 | Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules… | Phase1 | Fasting | Completed | 2007-03-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01505998 | Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules… | Phase1 | Fed | Completed | 2007-03-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01505998 | Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules… | Phase1 | Fed | Completed | 2007-03-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01136538 | Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under … | Phase1 | Healthy | Completed | 2007-02-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01132183 | Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Redd… | Phase1 | Healthy | Completed | 2007-02-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01132183 | Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Redd… | Phase1 | Healthy | Completed | 2007-02-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01159158 | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories … | Phase1 | Healthy | Completed | 2007-02-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT01159158 | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories … | Phase1 | Healthy | Completed | 2007-02-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT01136538 | Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under … | Phase1 | Healthy | Completed | 2007-02-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01133470 | Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER… | Phase1 | Healthy | Completed | 2007-02-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01136525 | Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under… | Phase1 | Healthy | Completed | 2007-02-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01136525 | Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under… | Phase1 | Healthy | Completed | 2007-02-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01133470 | Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER… | Phase1 | Healthy | Completed | 2007-02-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01045434 | Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditi… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01045642 | Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Co… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01056627 | Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsu… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01056627 | Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsu… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01133496 | Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under F… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01133496 | Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under F… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT01055938 | Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 … | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01045434 | Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditi… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01045642 | Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Co… | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01055938 | Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 … | Phase1 | Healthy | Completed | 2006-12-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT01264289 | Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Cond… | Phase1 | Healthy | Completed | 2006-11-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01503437 | Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fa… | Phase1 | Fasting | Completed | 2006-11-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT01503450 | Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fe… | Phase1 | Fed | Completed | 2006-11-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT01264289 | Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Cond… | Phase1 | Healthy | Completed | 2006-11-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01264302 | Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fast… | Phase1 | Healthy | Completed | 2006-11-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01503450 | Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fe… | Phase1 | Fed | Completed | 2006-11-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT01503437 | Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fa… | Phase1 | Fasting | Completed | 2006-11-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT01264302 | Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fast… | Phase1 | Healthy | Completed | 2006-11-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01512485 | Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01511718 | Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condi… | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01511705 | Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting C… | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01512485 | Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01511718 | Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condi… | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01511705 | Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting C… | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01064232 | Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Cond… | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01064271 | Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01064271 | Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01064232 | Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Cond… | Phase1 | Healthy | Completed | 2006-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01267396 | Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting C… | Phase1 | Healthy | Completed | 2006-09-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01506713 | Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting … | Phase1 | Fasting | Completed | 2006-09-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT01267396 | Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting C… | Phase1 | Healthy | Completed | 2006-09-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01267383 | Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditio… | Phase1 | Healthy | Completed | 2006-09-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01506713 | Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting … | Phase1 | Fasting | Completed | 2006-09-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT01267383 | Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditio… | Phase1 | Healthy | Completed | 2006-09-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT01132170 | Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Unde… | Phase1 | Healthy | Completed | 2006-08-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01132040 | Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Co… | Phase1 | Healthy | Completed | 2006-08-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT01132196 | Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2006-08-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01132196 | Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Unde… | Phase1 | Healthy | Completed | 2006-08-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01132040 | Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Co… | Phase1 | Healthy | Completed | 2006-08-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT01132170 | Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Unde… | Phase1 | Healthy | Completed | 2006-08-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01512459 | Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2006-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT01052792 | Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions | Phase1 | Healthy | Completed | 2006-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT01512459 | Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2006-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT01052129 | Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition | Phase1 | Healthy | Completed | 2006-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01052129 | Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition | Phase1 | Healthy | Completed | 2006-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01052792 | Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions | Phase1 | Healthy | Completed | 2006-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT01373138 | Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-rele… | Phase1 | Healthy | Completed | 2006-04-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01506791 | Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tabl… | Phase1 | Healthy | Completed | 2006-04-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01373138 | Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-rele… | Phase1 | Healthy | Completed | 2006-04-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01506791 | Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tabl… | Phase1 | Healthy | Completed | 2006-04-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01164787 | Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2006-03-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01164787 | Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2006-03-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01164800 | Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Cond… | Phase1 | Healthy | Completed | 2006-03-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01164813 | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2006-03-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01164826 | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Cond… | Phase1 | Healthy | Completed | 2006-03-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01164800 | Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Cond… | Phase1 | Healthy | Completed | 2006-03-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01164813 | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2006-03-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01164826 | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Cond… | Phase1 | Healthy | Completed | 2006-03-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01166087 | Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg… | Phase1 | Healthy | Completed | 2006-02-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT01170182 | Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Und… | Phase1 | Healthy | Completed | 2006-02-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01166100 | Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 m… | Phase1 | Healthy | Completed | 2006-02-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT01170182 | Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Und… | Phase1 | Healthy | Completed | 2006-02-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT01166087 | Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg… | Phase1 | Healthy | Completed | 2006-02-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT01166100 | Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 m… | Phase1 | Healthy | Completed | 2006-02-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT01170169 | Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Und… | Phase1 | Healthy | Completed | 2006-01-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01506050 | Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01506037 | Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01506050 | Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01506037 | Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01064102 | Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Unde… | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01064115 | Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Unde… | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01170169 | Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Und… | Phase1 | Healthy | Completed | 2006-01-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01064115 | Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Unde… | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01064102 | Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Unde… | Phase1 | Healthy | Completed | 2006-01-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01314339 | Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting … | Phase1 | Fasting | Completed | 2005-12-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01314352 | Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Con… | Phase1 | Fed | Completed | 2005-12-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01314339 | Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting … | Phase1 | Fasting | Completed | 2005-12-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT01314352 | Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Con… | Phase1 | Fed | Completed | 2005-12-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT01164774 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Li… | Phase1 | Healthy | Completed | 2005-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT01164774 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Li… | Phase1 | Healthy | Completed | 2005-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT01164761 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Li… | Phase1 | Healthy | Completed | 2005-09-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT01164761 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Li… | Phase1 | Healthy | Completed | 2005-09-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT01269281 | Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions | Phase1 | Healthy | Completed | 2005-07-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT01269281 | Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions | Phase1 | Healthy | Completed | 2005-07-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT01155908 | Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochlori… | Phase1 | Healthy | Completed | 2005-04-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT01155908 | Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochlori… | Phase1 | Healthy | Completed | 2005-04-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT01372345 | Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under … | Phase1 | Fasting | Completed | 2005-02-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT01372345 | Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under … | Phase1 | Fasting | Completed | 2005-02-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT01160068 | Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. … | Phase1 | Healthy | Completed | 2005-02-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT01160068 | Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. … | Phase1 | Healthy | Completed | 2005-02-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT01167894 | Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2005-01-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT01161979 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2005-01-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT01161966 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2005-01-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT01160042 | Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. … | Phase1 | Healthy | Completed | 2005-01-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT01161979 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2005-01-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT01161966 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2005-01-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT01167933 | Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Con… | Phase1 | Healthy | Completed | 2005-01-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT01167894 | Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2005-01-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT01160042 | Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. … | Phase1 | Healthy | Completed | 2005-01-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT01167933 | Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Con… | Phase1 | Healthy | Completed | 2005-01-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT01372358 | Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under … | Phase1 | Fed | Completed | 2005-01-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT01372358 | Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under … | Phase1 | Fed | Completed | 2005-01-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT01581879 | Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fe… | Phase1 | Healthy | Completed | 2004-11-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT01581866 | Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2004-11-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT01581866 | Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2004-11-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT01581879 | Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fe… | Phase1 | Healthy | Completed | 2004-11-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT01372280 | Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition | Phase1 | Fasting | Completed | 2004-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01131780 | Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets … | Phase1 | Healthy | Completed | 2004-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01283932 | Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Lab… | Phase1 | FED | Completed | 2004-10-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT01131780 | Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets … | Phase1 | Healthy | Completed | 2004-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01160029 | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories … | Phase1 | Healthy | Completed | 2004-10-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT01161147 | Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limi… | Phase1 | Healthy | Completed | 2004-10-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT01372306 | Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition | Phase1 | Fed | Completed | 2004-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01283919 | Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Lab… | Phase1 | Fasting | Completed | 2004-10-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT01283932 | Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Lab… | Phase1 | FED | Completed | 2004-10-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT01372280 | Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition | Phase1 | Fasting | Completed | 2004-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01372306 | Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition | Phase1 | Fed | Completed | 2004-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01283919 | Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Lab… | Phase1 | Fasting | Completed | 2004-10-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT01161147 | Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limi… | Phase1 | Healthy | Completed | 2004-10-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT01160029 | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories … | Phase1 | Healthy | Completed | 2004-10-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT01132222 | Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Un… | Phase1 | Healthy | Completed | 2004-09-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT01161134 | Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limi… | Phase1 | Healthy | Completed | 2004-09-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01161134 | Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limi… | Phase1 | Healthy | Completed | 2004-09-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT01132222 | Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Un… | Phase1 | Healthy | Completed | 2004-09-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT01155921 | Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.R… | Phase1 | Healthy | Completed | 2004-08-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT01155921 | Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.R… | Phase1 | Healthy | Completed | 2004-08-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT01155934 | Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.R… | Phase1 | Healthy | Completed | 2004-08-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT01155934 | Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.R… | Phase1 | Healthy | Completed | 2004-08-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT01131767 | Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER … | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01131728 | Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER … | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01161927 | Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01161927 | Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01161940 | Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01161940 | Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories L… | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01131728 | Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER … | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01131767 | Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER … | Phase1 | Healthy | Completed | 2004-07-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT01155895 | Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochlori… | Phase1 | Healthy | Completed | 2004-03-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT01155895 | Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochlori… | Phase1 | Healthy | Completed | 2004-03-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT01146041 | Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Co… | Phase1 | Healthy | Completed | 2004-02-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT01146041 | Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Co… | Phase1 | Healthy | Completed | 2004-02-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT01146067 | Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions | Phase1 | Healthy | Completed | 2004-01-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT01146067 | Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions | Phase1 | Healthy | Completed | 2004-01-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT01053689 | Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablet… | Phase1 | Healthy | Completed | 2003-12-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT01053689 | Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablet… | Phase1 | Healthy | Completed | 2003-12-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT01052909 | Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 … | Phase1 | Healthy | Completed | 2003-12-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT01052909 | Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 … | Phase1 | Healthy | Completed | 2003-12-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT01149980 | Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Lab… | Phase1 | Healthy | Completed | 2003-10-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01149980 | Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Lab… | Phase1 | Healthy | Completed | 2003-10-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01149967 | Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Lab… | Phase1 | Healthy | Completed | 2003-10-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01149967 | Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Lab… | Phase1 | Healthy | Completed | 2003-10-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01131897 | Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fas… | Phase1 | Healthy | Completed | 2003-09-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01132352 | Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed … | Phase1 | Healthy | Completed | 2003-09-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01132352 | Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed … | Phase1 | Healthy | Completed | 2003-09-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01131897 | Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fas… | Phase1 | Healthy | Completed | 2003-09-01 | 2003-11-01 | ClinicalTrials.gov |
| NCT01149954 | Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Labor… | Phase1 | Healthy | Completed | 2003-01-01 | 2003-01-01 | ClinicalTrials.gov |
| NCT01149954 | Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Labor… | Phase1 | Healthy | Completed | 2003-01-01 | 2003-01-01 | ClinicalTrials.gov |
| NCT01131702 | Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2003-01-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01131702 | Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting … | Phase1 | Healthy | Completed | 2003-01-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01131949 | Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under … | Phase1 | Healthy | Completed | 2003-01-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01131949 | Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under … | Phase1 | Healthy | Completed | 2003-01-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01131975 | Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under … | Phase1 | Healthy | Completed | 2003-01-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01131975 | Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under … | Phase1 | Healthy | Completed | 2003-01-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01513720 | Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2002-12-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT01146106 | Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditio… | Phase1 | Healthy | Completed | 2002-12-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT01513720 | Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2002-12-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT01146106 | Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditio… | Phase1 | Healthy | Completed | 2002-12-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT01513681 | Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition | Phase1 | Healthy | Completed | 2002-11-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01146093 | Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2002-11-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01149941 | Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratori… | Phase1 | Healthy | Completed | 2002-11-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01149941 | Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratori… | Phase1 | Healthy | Completed | 2002-11-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01513681 | Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition | Phase1 | Healthy | Completed | 2002-11-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01146093 | Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2002-11-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT01131923 | Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under… | Phase1 | Healthy | Completed | 2002-10-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT01131923 | Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under… | Phase1 | Healthy | Completed | 2002-10-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT01131936 | Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under… | Phase1 | Healthy | Completed | 2002-08-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01131936 | Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under… | Phase1 | Healthy | Completed | 2002-08-01 | 2002-11-01 | ClinicalTrials.gov |
| NCT01511770 | Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2002-08-01 | 2002-09-01 | ClinicalTrials.gov |
| NCT01888341 | Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2002-08-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT01888341 | Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2002-08-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT01511770 | Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 2002-08-01 | 2002-09-01 | ClinicalTrials.gov |
| NCT01511757 | Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2002-06-01 | 2002-07-01 | ClinicalTrials.gov |
| NCT01511757 | Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions | Phase1 | Healthy | Completed | 2002-06-01 | 2002-07-01 | ClinicalTrials.gov |
| NCT01064180 | Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under … | Phase1 | Healthy | Completed | 2002-05-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01064180 | Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under … | Phase1 | Healthy | Completed | 2002-05-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01064154 | Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under … | Phase1 | Healthy | Completed | 2002-05-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01064154 | Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under … | Phase1 | Healthy | Completed | 2002-05-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01066754 | Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Un… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01066767 | Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochlo… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01066754 | Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Un… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01066767 | Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochlo… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01133444 | Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01133457 | Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 m… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01133444 | Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01133457 | Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 m… | Phase1 | Healthy | Completed | 2002-04-01 | 2002-05-01 | ClinicalTrials.gov |
| NCT01286688 | Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy'… | Phase1 | Fasting | Completed | 2002-01-01 | 2002-03-01 | ClinicalTrials.gov |
| NCT01286688 | Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy'… | Phase1 | Fasting | Completed | 2002-01-01 | 2002-03-01 | ClinicalTrials.gov |
| NCT01286701 | Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy'… | Phase1 | Healthy | Completed | 2002-01-01 | 2002-03-01 | ClinicalTrials.gov |
| NCT01286701 | Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy'… | Phase1 | Healthy | Completed | 2002-01-01 | 2002-03-01 | ClinicalTrials.gov |
| NCT01146028 | Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting … | Phase1 | Healthy | Completed | 2001-09-01 | 2001-11-01 | ClinicalTrials.gov |
| NCT01065987 | Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Cond… | Phase1 | Healthy | Completed | 2001-09-01 | 2001-11-01 | ClinicalTrials.gov |
| NCT01146028 | Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting … | Phase1 | Healthy | Completed | 2001-09-01 | 2001-11-01 | ClinicalTrials.gov |
| NCT01065987 | Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Cond… | Phase1 | Healthy | Completed | 2001-09-01 | 2001-11-01 | ClinicalTrials.gov |
| NCT01888289 | Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2001-07-01 | 2001-09-01 | ClinicalTrials.gov |
| NCT01888289 | Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition | Phase1 | Healthy | Completed | 2001-07-01 | 2001-09-01 | ClinicalTrials.gov |
| NCT01888328 | Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition | Phase1 | Healthy | Completed | 2001-05-01 | 2001-06-01 | ClinicalTrials.gov |
| NCT01888328 | Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition | Phase1 | Healthy | Completed | 2001-05-01 | 2001-06-01 | ClinicalTrials.gov |
| NCT01511731 | Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 1998-10-01 | 1998-10-01 | ClinicalTrials.gov |
| NCT01511731 | Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions | Phase1 | Healthy | Completed | 1998-10-01 | 1998-10-01 | ClinicalTrials.gov |
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any M… | — | HIV Infections | Recruiting | 1989-01-01 | 2099-01-01 | ClinicalTrials.gov |
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any M… | — | HIV Infections | Recruiting | 1989-01-01 | 2099-01-01 | ClinicalTrials.gov |
Total clinical trials: 468
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| E7777 | Other | Phase PHASE1 | Epithelial Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT05200559 |
| Pembrolizumab | Other | Phase PHASE1 | Epithelial Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT05200559 |
| Divalproex Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01132170 |
| Tacrolimus Capsules | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01132027 |
| Tacrolimus Capsules | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131988 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131975 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131949 |
| Amlodipine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131936 |
| Amlodipine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131923 |
| Pravastatin Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01146106 |
| Rivastigmine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01146041 |
| Ibuprofen | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01149941 |
| Desloratadine | Other | Phase PHASE1 | Fed | COMPLETED | NCT01314352 |
| Clopidogrel | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01506713 |
| Desloratadine | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01314339 |
| Tetrabenazine Tablets 25 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03696329 |
| MabThera | Other | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT02296775 |
| Rituxan | Other | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT02296775 |
| DRL_RI | Other | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT02296775 |
| Placebo Comparator | Other | Phase PHASE3 | Covid19 | TERMINATED | NCT04529499 |
| AVIGAN | Other | Phase PHASE3 | Covid19 | TERMINATED | NCT04529499 |
| Naproxen Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01052792 |
| Omeprazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01045642 |
| Omeprazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01045434 |
| Glimepiride tablets 1 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01053689 |
| Ibuprofen and Diphenhydramine Citrate | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01053338 |
| Ibuprofen and Diphenhydramine Citrate | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01053208 |
| Glimepiride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01052909 |
| Divalproex Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01056627 |
| Divalproex Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01055938 |
| Risperidone | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01064271 |
| Risperidone | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01064232 |
| Carvedilol | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01064180 |
| Carvedilol | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01064154 |
| Cetirizine Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01064115 |
| Cetirizine Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01064102 |
| Fexofenadine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01066767 |
| Fexofenadine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01066754 |
| Tizanidine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01065987 |
| Divalproex Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01132183 |
| Primidone | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01132040 |
| Naproxen sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01052129 |
| Finasteride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01133457 |
| Ranitidine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131702 |
| Valacyclovir Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01136538 |
| Valacyclovir Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01136525 |
| Alendronate Sodium Tablets, 70 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01133496 |
| Fexofenadine HCl + Pseudoephedrine HCl | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01133483 |
| Fexofenadine HCl + Pseudoephedrine HCl | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01133470 |
| Levetiracetam | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01132352 |
| Ibuprofen + Pseudoephedrine Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01132222 |
| Divalproex Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01132196 |
| Levetiracetam | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131897 |
| Ibuprofen + Pseudoephedrine Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131780 |
| Naproxen Sodium & Pseudoephedrine HCl | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131767 |
| Naproxen Sodium & Pseudoephedrine HCl | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01131728 |
| Citalopram Hydrobromide | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01149980 |
| Citalopram Hydrobromide | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01149967 |
| Ibuprofen | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01149954 |
| Anastrozole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01155960 |
| Anastrozole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01155947 |
| Risperidone Orally Disintegrating Tablets | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01155934 |
| Risperidone Orally Disintegrating Tablets | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01155921 |
| Amlodipine Besylate / Benazepril Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01155908 |
| Amlodipine Besylate / Benazepril Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01155895 |
| Finasteride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01133444 |
| Meloxicam | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161147 |
| Meloxicam | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161134 |
| Glucophage | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01160068 |
| Metformin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01160068 |
| Nateglinide | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01160029 |
| Nateglinide | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01159158 |
| Zonegran | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161979 |
| Zonisamide | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161979 |
| Zonegran | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161966 |
| Zonisamide | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161966 |
| Axid | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161940 |
| Nizatidine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161940 |
| Axid | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161927 |
| Nizatidine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01161927 |
| Relafen | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164826 |
| Nabumetone | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164826 |
| Relafen | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164813 |
| Nabumetone | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164813 |
| Mavik | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164800 |
| Trandolapril | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164800 |
| Mavik | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164787 |
| Trandolapril | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164787 |
| Altace | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164774 |
| Ramipril | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164774 |
| Altace | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164761 |
| Ramipril | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01164761 |
| Fluoxetine Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01166100 |
| Fluoxetine Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01166087 |
| Simvastatin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01167894 |
| Glucophage | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01160042 |
| Metformin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01160042 |
| Prilosec® 40 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01170182 |
| Omeprazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01170182 |
| Prilosec | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01170169 |
| Omeprazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01170169 |
| Simvastatin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01167933 |
| Finasteride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01264302 |
| Finasteride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01264289 |
| Sumatriptan | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01269281 |
| Lansoprazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01270308 |
| Pantoprazole Sodium | Other | Phase PHASE1 | FED | COMPLETED | NCT01283932 |
| Pantoprazole Sodium | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01283919 |
| Mycophenolate Mofetil | Other | Phase PHASE1 | FED | COMPLETED | NCT01283867 |
| Mycophenolate Mofetil | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01283841 |
| Zafirlukast | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01283061 |
| CIPRO®XR | Other | Phase PHASE1 | Fed | COMPLETED | NCT01372358 |
| CIPRO®XR | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01372345 |
| Desloratadine and pseudoephedrine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01373138 |
| Letrozole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01372982 |
| Letrozole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01375452 |
| Reminyl | Other | Phase PHASE1 | Fed | COMPLETED | NCT01372306 |
| Reminyl | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01372280 |
| Olanzapine OD Tablets 5 mg | Other | Phase PHASE1 | Fed | COMPLETED | NCT01503450 |
| Olanzapine OD Tablets 5 mg | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01503437 |
| Olanzapine | Other | Phase PHASE1 | Fed | COMPLETED | NCT01503424 |
| Olanzapine | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01503398 |
| Aricept | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01504516 |
| Donepezil Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01504516 |
| Aricept | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01504503 |
| Donepezil Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01504503 |
| Levocetirizine DiHCl | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01506076 |
| Desloratadine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01506050 |
| Amlodipine Besylate/Benazepril HCl | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01506011 |
| Amlodipine Besylate/Benazepril HCl | Other | Phase PHASE1 | Fed | COMPLETED | NCT01505998 |
| Desloratadine and pseudoephedrine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01506791 |
| Levocetirizine DiHCl | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01506063 |
| Desloratadine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01506037 |
| Terbinafine Hydrochloride Tablets, 250 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01286701 |
| Terbinafine Hydrochloride Tablets, 250 mg | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01286688 |
| Sertraline | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01267396 |
| Sertraline | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01267383 |
| Pravastatin Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01146093 |
| Rivastigmine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01146067 |
| Tizanidine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01146028 |
| Clopidogrel | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01512485 |
| Venlafaxine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01512459 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01511770 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01511757 |
| Pepcid | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01511731 |
| Famotidine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01511731 |
| Ondansetron Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01511718 |
| Ondansetron Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01511705 |
| Lamictal® | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01513720 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01513720 |
| Lamictal® | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01513681 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01513681 |
| Mycophenolate Mofetil | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01513057 |
| Mycophenolate Mofetil | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01513044 |
| Quetiapine fumarate | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01566487 |
| Ziprasidone Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01581879 |
| Ziprasidone Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01581866 |
| Divalproex Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01581788 |
| Divalproex Sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01581775 |
| Clopidogrel | Other | Phase PHASE1 | Fasting | COMPLETED | NCT01621750 |
| Clopidogrel | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01621763 |
| Ibandronate sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01627886 |
| Atorvastatin Calcium Tablets, 80 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01645449 |
| Atorvastatin Calcium Tablets, 80 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01645423 |
| Atorvastatin Calcium Tablets, 40 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01645410 |
| Atorvastatin Calcium Tablets, 40 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01645384 |
| Montelukast sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01671722 |
| Montelukast sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01671709 |
| Montelukast sodium chewable tablets 4mg and 5mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01674517 |
| Montelukast sodium chewable tablets 4 mg and 5 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01674504 |
| Montelukast sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01691469 |
| Montelukast sodium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01691456 |
| Metoprolol Succinate | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01673997 |
| Metoprolol Succinate | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01694797 |
| Ropinirole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01627847 |
| Ropinirole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01627834 |
| Usual cardiovascular medications | Drug | Phase PHASE3 | Cardiovascular Diseases | COMPLETED | NCT01057537 |
| polypill | Other | Phase PHASE3 | Cardiovascular Diseases | COMPLETED | NCT01057537 |
| Metronidazole-DRF2 | Other | Phase PHASE2 | Clostridium Difficile Associated Diarrhea | COMPLETED | NCT01559545 |
| Metronidazole-DRF1 | Other | Phase PHASE2 | Clostridium Difficile Associated Diarrhea | COMPLETED | NCT01559545 |
| Metronidazole | Other | Phase PHASE2 | Clostridium Difficile Associated Diarrhea | COMPLETED | NCT01559545 |
| Isotretinoin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888341 |
| Isotretinoin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888328 |
| Isotretinoin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888289 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888263 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888250 |
| Isotretinoin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888224 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888757 |
| Lamotrigine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888731 |
| Fexofenadine Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01888718 |
| Donepezil | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01923558 |
| Donepezil | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01923259 |
| Placebo | Other | Phase PHASE3 | Chronic Idiopathic Constipation | COMPLETED | NCT01674530 |
| Lubiprostone | Other | Phase PHASE3 | Chronic Idiopathic Constipation | COMPLETED | NCT01674530 |
| DRL-17822 or placebo | Other | Phase PHASE2 | Type II Hyperlipidemia | COMPLETED | NCT01388816 |
| omeprazole | Other | Phase PHASE4 | GERD | UNKNOWN | NCT02140073 |
| omeprazole+domperidone SR | Other | Phase PHASE4 | GERD | UNKNOWN | NCT02140073 |
| Pegfilgrastim Form B | Other | Phase PHASE1 | Pharmacokinetics | UNKNOWN | NCT02205320 |
| Pegfilgrastim Form A | Other | Phase PHASE1 | Pharmacokinetics | UNKNOWN | NCT02205320 |
| DRL_PG | Other | Phase PHASE1 | Pharmacokinetics | UNKNOWN | NCT02205320 |
| Placebo | Other | Phase PHASE1 | Surgical Site Infection | COMPLETED | NCT01496352 |
| DFA-02 | Other | Phase PHASE1 | Surgical Site Infection | COMPLETED | NCT01496352 |
| Cymbalta® | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02291367 |
| Duloxetine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02291367 |
| Cymbalta® | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02291341 |
| Duloxetine | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02291341 |
| Amlodipine besylate/Atorvastatin calcium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02292069 |
| Amlodipine besylate/Atorvastatin calcium | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02295046 |
| Sirolimus | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02296762 |
| Sirolimus | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02296749 |
| Valganciclovir Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02296723 |
| Valganciclovir Hydrochloride | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02297854 |
| Eszopiclone Tablets 3 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02322658 |
| Eszopiclone Tablets 3 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02322645 |
| Paricalcitol Capsules, 4 mcg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02322632 |
| Moxifloxacin Tablets 400 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT02322619 |
| Placebo | Other | Phase PHASE3 | Chemotherapy Induced Nausea and Vomiting | COMPLETED | NCT01402024 |
| Aprepitant | Other | Phase PHASE3 | Chemotherapy Induced Nausea and Vomiting | COMPLETED | NCT01402024 |
| Levofloxacin 500 | Other | Preclinical | Chronic Prostatitis | COMPLETED | NCT02711943 |
| Amoxicillin-Potassium Clavulanate Combination | Other | Preclinical | Rhinosinusitis | COMPLETED | NCT02712502 |
| Levofloxacin | Other | Preclinical | Rhinosinusitis | COMPLETED | NCT02712502 |
| Active01 Cream | Other | Phase PHASE2 | Common Warts | COMPLETED | NCT02798419 |
| DFD05 Cream | Other | Phase PHASE2 | Common Warts | COMPLETED | NCT02798419 |
| Doxorubicin Hydrochloride Liposome Injection | Other | Phase PHASE1 | Ovarian Epithelial Cancer Recurrent | COMPLETED | NCT02260544 |
| NISELAT | Other | Preclinical | Knee Osteoarthritis | COMPLETED | NCT02865161 |
| NISE | Other | Phase PHASE4 | Knee Osteoarthritis | COMPLETED | NCT02922712 |
| OMEZ 80 | Other | Phase PHASE4 | GERD | COMPLETED | NCT02922699 |
| OMEZ 40 | Other | Phase PHASE4 | GERD | COMPLETED | NCT02922699 |
| DFA-02 Placebo Gel | Other | Phase PHASE2 | Surgical Site Infections | COMPLETED | NCT01888367 |
| DFA-02 Antibiotic Gel | Other | Phase PHASE2 | Surgical Site Infections | COMPLETED | NCT01888367 |
| Permethrin | Other | Phase PHASE3 | Scabies | COMPLETED | NCT02572986 |
| Ketoprofen | Other | Phase PHASE4 | Gonarthrosis | COMPLETED | NCT02638831 |
| Ketorolac Tromethamine | Other | Phase PHASE4 | Gonarthrosis | COMPLETED | NCT02638831 |
| Levofloxacin | Other | Phase PHASE4 | Urinary Tract Infection | UNKNOWN | NCT03160807 |
| Comparator Celebrex® (fed) | Other | Phase PHASE1 | Migraine | COMPLETED | NCT03282838 |
| DFN-15 (fed) | Other | Phase PHASE1 | Migraine | COMPLETED | NCT03282838 |
| DFN-15 (fasted) | Other | Phase PHASE1 | Migraine | COMPLETED | NCT03282838 |
| Active Comparator | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-15 Dose 3 | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-15 Dose 2 | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-15 Dose 1 | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-02 | Other | Phase PHASE3 | Acute Migraine | COMPLETED | NCT02279082 |
| Doxycycline | Other | Phase PHASE1 | Rosacea | COMPLETED | NCT03478436 |
| DFN-11 Injection | Other | Phase PHASE2 | Medication Overuse Headache | TERMINATED | NCT02583425 |
| Placebo (treatment C) | Drug | Phase PHASE2 | Migraine | COMPLETED | NCT02472418 |
| DFN-15 Dose B (treatment B) | Drug | Phase PHASE2 | Migraine | COMPLETED | NCT02472418 |
| DFN-15 Dose A (treatment A) | Drug | Phase PHASE2 | Migraine | COMPLETED | NCT02472418 |
| Placebo | Other | Phase PHASE3 | Episodic Migraine | COMPLETED | NCT02569853 |
| DFN-11 | Other | Phase PHASE3 | Episodic Migraine | COMPLETED | NCT02569853 |
| Tetrabenazine Tablets 25 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03702855 |
| Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03706300 |
| Placebo Ointment | Other | Phase PHASE2 | Rosacea | COMPLETED | NCT02828241 |
| DFD-04 Ointment | Other | Phase PHASE2 | Rosacea | COMPLETED | NCT02828241 |
| DFN-11 | Other | Phase PHASE2 | Rapidly Escalating Migraine | COMPLETED | NCT02571049 |
| Placebo | Other | Phase PHASE2 | Migraine With Aura | COMPLETED | NCT03472378 |
| DFN-15 | Other | Phase PHASE2 | Migraine With Aura | COMPLETED | NCT03472378 |
| Placebo twice daily | Other | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| High dose DFD07 twice daily | Other | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| High dose DFD07 once daily | Other | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| Low dose DFD07 once daily | Other | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| Panitumumab | Other | Phase PHASE4 | Cancer | UNKNOWN | NCT02301962 |
| Ha44 Gel | Other | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT01907490 |
| Vehicle Lotion | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02062073 |
| saline 0.9% | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02062073 |
| 0.1% sodium lauryl sulfate | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02062073 |
| Abametapir Lotion 0.74% w/w | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02062073 |
| Group C - Placebo | Other | Phase PHASE2 | Pediculosis | COMPLETED | NCT01336647 |
| Group B - High Dose Ha44 Gel 0.74% w/w | Other | Phase PHASE2 | Pediculosis | COMPLETED | NCT01336647 |
| Group A - Low-Dose Ha44 0.37% w/w | Other | Phase PHASE2 | Pediculosis | COMPLETED | NCT01336647 |
| Vehicle Lotion | Other | Phase PHASE3 | Head Lice Infestation | COMPLETED | NCT02062060 |
| Abametapir Lotion 0.74% w/w | Other | Phase PHASE3 | Head Lice Infestation | COMPLETED | NCT02062060 |
| Ha44 Gel 0.74% w/w | Other | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT02010333 |
| Tazorac Vehicle Cream 0% | Other | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| DFD-03 Vehicle Lotion 0% | Other | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| Tazorac Cream, 0.1% | Other | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| DFD-03 Lotion, 0.1% | Other | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| Vehicle Lotion | Other | Phase PHASE3 | Head Lice Infestation | COMPLETED | NCT02060903 |
| Abametapir Lotion 0.74% w/w | Other | Phase PHASE3 | Head Lice Infestation | COMPLETED | NCT02060903 |
| Placebo | Other | Phase PHASE2 | Acute Pain | COMPLETED | NCT03554772 |
| DFN-15 (Celecoxib Oral Solution) 250 mg | Other | Phase PHASE2 | Acute Pain | COMPLETED | NCT03554772 |
| DFN-15 (Celecoxib Oral Solution) 125 mg | Other | Phase PHASE2 | Acute Pain | COMPLETED | NCT03554772 |
| DFN-15 (Celecoxib Oral Solution) 62.5 mg | Other | Phase PHASE2 | Acute Pain | COMPLETED | NCT03554772 |
| Tazarotene Cream, 0.1% | Other | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03599193 |
| Tazarotene Lotion, 0.1% | Other | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03599193 |
| Placebo Capsules | Other | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| Oraycea® (doxycycline) Capsules | Other | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| DFD-29 Extended Release Capsules (20 mg) | Other | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| DFD-29 Extended Release Capsules (40 mg) | Other | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| DFD-03 (0% tazarotene) Lotion (Placebo) | Other | Phase PHASE3 | Acne Vulgaris | COMPLETED | NCT03292640 |
| DFD-03 (0.1% tazarotene) Lotion | Other | Phase PHASE3 | Acne Vulgaris | COMPLETED | NCT03292640 |
| Placebo Comparator | Other | Phase PHASE3 | Acne Vulgaris | COMPLETED | NCT03290027 |
| DFD-03 | Other | Phase PHASE3 | Acne Vulgaris | COMPLETED | NCT03290027 |
| Vehicle Lotion | Other | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT02097485 |
| Abametapir Lotion 0.74% w/w | Other | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT02097485 |
| Placebo | Other | Phase PHASE2 | COVID-19 Prevention | UNKNOWN | NCT04640233 |
| Gam-COVID-Vac | Other | Phase PHASE2 | COVID-19 Prevention | UNKNOWN | NCT04640233 |
| Moxifloxacin | Other | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Moxifloxacin Placebo | Other | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Ha44 Placebo | Other | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Ha44 | Other | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Placebo | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02061813 |
| Saline 0.9% | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02061813 |
| Sodium Lauryl Sulfate | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02061813 |
| Abametapir Lotion 0.74% w/w | Other | Phase PHASE1 | Head Lice | COMPLETED | NCT02061813 |
| Placebo | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT03421197 |
| PPC-06 600 mg | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT03421197 |
| PPC-06 400 mg BID | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT03421197 |
| PPC-06 400 mg QD | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT03421197 |
| Placebo | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT02173301 |
| XP23829 400 mg BID | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT02173301 |
| XP 23829 800 mg QD | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT02173301 |
| XP23829 400 mg QD | Other | Phase PHASE2 | Psoriasis | COMPLETED | NCT02173301 |
| DFN-15 Placebo | Other | Phase PHASE3 | Migraine Headache | COMPLETED | NCT03009019 |
| DFN-15 Active | Other | Phase PHASE3 | Migraine Headache | COMPLETED | NCT03009019 |
| Reference Medicinal Product | Other | Phase PHASE1 | Rheumatoid Arthritis | UNKNOWN | NCT06126042 |
| Reference product | Other | Phase PHASE1 | Rheumatoid Arthritis | UNKNOWN | NCT06126042 |
| Test Product | Other | Phase PHASE1 | Rheumatoid Arthritis | UNKNOWN | NCT06126042 |
| Arm B: Rituxan®/Mabthera® | Other | Phase PHASE3 | Rheumatoid Arthritis | COMPLETED | NCT04268771 |
| Experimental: Arm A: DRL_RI | Other | Phase PHASE3 | Rheumatoid Arthritis | COMPLETED | NCT04268771 |
| Tocilizumab Prefilled Syringe | Other | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT04885829 |
| MabThera® | Other | Phase PHASE3 | Follicular Lymphoma | COMPLETED | NCT03976102 |
| DRL_RI (Proposed rituximab biosimilar) | Other | Phase PHASE3 | Follicular Lymphoma | COMPLETED | NCT03976102 |
| E7777 | Other | Phase PHASE1 | Epithelial Ovarian Cancer | RECRUITING | NCT05200559 |
| Pembrolizumab | Other | Phase PHASE1 | Epithelial Ovarian Cancer | RECRUITING | NCT05200559 |
| Keytruda | BIOLOGICAL | Phase PHASE1 | Melanoma | NOT_YET_RECRUITING | NCT07475572 |
| AVT32-DRL_PB | BIOLOGICAL | Phase PHASE1 | Melanoma | NOT_YET_RECRUITING | NCT07475572 |
| Reference Medicinal Product | DRUG | Phase PHASE1 | Rheumatoid Arthritis | RECRUITING | NCT06126042 |
| Reference product | DRUG | Phase PHASE1 | Rheumatoid Arthritis | RECRUITING | NCT06126042 |
| Test Product | DRUG | Phase PHASE1 | Rheumatoid Arthritis | RECRUITING | NCT06126042 |
| Tocilizumab Prefilled Syringe | DRUG | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT04885829 |
| Gam-COVID-Vac | BIOLOGICAL | Phase PHASE2 | COVID-19 Prevention | UNKNOWN | NCT04640233 |
| AVIGAN | DRUG | Phase PHASE3 | Covid19 | TERMINATED | NCT04529499 |
| Arm B: Rituxan®/Mabthera® | BIOLOGICAL | Phase PHASE3 | Rheumatoid Arthritis | COMPLETED | NCT04268771 |
| Experimental: Arm A: DRL_RI | BIOLOGICAL | Phase PHASE3 | Rheumatoid Arthritis | COMPLETED | NCT04268771 |
| MabThera® | OTHER | Phase PHASE3 | Follicular Lymphoma | COMPLETED | NCT03976102 |
| DRL_RI (Proposed rituximab biosimilar) | BIOLOGICAL | Phase PHASE3 | Follicular Lymphoma | COMPLETED | NCT03976102 |
| Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT03706300 |
| Tetrabenazine Tablets 25 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT03702855 |
| Tazarotene Cream, 0.1% | DRUG | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03599193 |
| Tazarotene Lotion, 0.1% | DRUG | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03599193 |
| DFN-15 (Celecoxib Oral Solution) 250 mg | DRUG | Phase PHASE2 | Acute Pain | COMPLETED | NCT03554772 |
| DFN-15 (Celecoxib Oral Solution) 125 mg | DRUG | Phase PHASE2 | Acute Pain | COMPLETED | NCT03554772 |
| DFN-15 (Celecoxib Oral Solution) 62.5 mg | DRUG | Phase PHASE2 | Acute Pain | COMPLETED | NCT03554772 |
| Doxycycline | DRUG | Phase PHASE1 | Rosacea | COMPLETED | NCT03478436 |
| DFN-15 | DRUG | Phase PHASE2 | Migraine With Aura | COMPLETED | NCT03472378 |
| PPC-06 600 mg | DRUG | Phase PHASE2 | Psoriasis | COMPLETED | NCT03421197 |
| PPC-06 400 mg BID | DRUG | Phase PHASE2 | Psoriasis | COMPLETED | NCT03421197 |
| PPC-06 400 mg QD | DRUG | Phase PHASE2 | Psoriasis | COMPLETED | NCT03421197 |
| Tazorac Vehicle Cream 0% | DRUG | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| DFD-03 Vehicle Lotion 0% | DRUG | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| Tazorac Cream, 0.1% | DRUG | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| DFD-03 Lotion, 0.1% | DRUG | Phase PHASE2 | Acne Vulgaris | COMPLETED | NCT03341910 |
| Placebo Capsules | DRUG | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| Oraycea® (doxycycline) Capsules | DRUG | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| DFD-29 Extended Release Capsules (20 mg) | DRUG | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| DFD-29 Extended Release Capsules (40 mg) | DRUG | Phase PHASE2 | Rosacea | COMPLETED | NCT03340961 |
| DFD-03 (0% tazarotene) Lotion (Placebo) | DRUG | Phase PHASE3 | Acne Vulgaris | COMPLETED | NCT03292640 |
| DFD-03 (0.1% tazarotene) Lotion | DRUG | Phase PHASE3 | Acne Vulgaris | COMPLETED | NCT03292640 |
| Placebo Comparator | DRUG | Phase PHASE3 | Covid19 | TERMINATED | NCT04529499 |
| DFD-03 | DRUG | Phase PHASE3 | Acne Vulgaris | COMPLETED | NCT03290027 |
| Comparator Celebrex® (fed) | DRUG | Phase PHASE1 | Migraine | COMPLETED | NCT03282838 |
| DFN-15 (fed) | DRUG | Phase PHASE1 | Migraine | COMPLETED | NCT03282838 |
| DFN-15 (fasted) | DRUG | Phase PHASE1 | Migraine | COMPLETED | NCT03282838 |
| Placebo twice daily | DRUG | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| High dose DFD07 twice daily | DRUG | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| High dose DFD07 once daily | DRUG | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| Low dose DFD07 once daily | DRUG | Phase PHASE2 | Actinic Keratosis (AK) | COMPLETED | NCT03116698 |
| Active Comparator | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-15 Dose 3 | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-15 Dose 2 | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-15 Dose 1 | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT03051685 |
| DFN-15 Placebo | OTHER | Phase PHASE3 | Migraine Headache | COMPLETED | NCT03009019 |
| DFN-15 Active | DRUG | Phase PHASE3 | Migraine Headache | COMPLETED | NCT03009019 |
| NISE | DRUG | Phase PHASE4 | Knee Osteoarthritis | COMPLETED | NCT02922712 |
| OMEZ 80 | DRUG | Phase PHASE4 | GERD | COMPLETED | NCT02922699 |
| OMEZ 40 | DRUG | Phase PHASE4 | GERD | COMPLETED | NCT02922699 |
| NISELAT | DRUG | Preclinical | Knee Osteoarthritis | COMPLETED | NCT02865161 |
| Placebo Ointment | OTHER | Phase PHASE2 | Rosacea | COMPLETED | NCT02828241 |
| DFD-04 Ointment | DRUG | Phase PHASE2 | Rosacea | COMPLETED | NCT02828241 |
| Amoxicillin-Potassium Clavulanate Combination | DRUG | Preclinical | Rhinosinusitis | COMPLETED | NCT02712502 |
| Levofloxacin | DRUG | Phase PHASE4 | Urinary Tract Infection | UNKNOWN | NCT03160807 |
| Levofloxacin 500 | DRUG | Preclinical | Chronic Prostatitis | COMPLETED | NCT02711943 |
| Ketoprofen | DRUG | Phase PHASE4 | Gonarthrosis | COMPLETED | NCT02638831 |
| Ketorolac Tromethamine | DRUG | Phase PHASE4 | Gonarthrosis | COMPLETED | NCT02638831 |
| DFN-11 Injection | DRUG | Phase PHASE2 | Medication Overuse Headache | TERMINATED | NCT02583425 |
| Permethrin | DRUG | Phase PHASE3 | Scabies | COMPLETED | NCT02572986 |
| DFN-11 | DRUG | Phase PHASE2 | Rapidly Escalating Migraine | COMPLETED | NCT02571049 |
| Placebo (treatment C) | OTHER | Phase PHASE2 | Migraine | COMPLETED | NCT02472418 |
| DFN-15 Dose B (treatment B) | DRUG | Phase PHASE2 | Migraine | COMPLETED | NCT02472418 |
| DFN-15 Dose A (treatment A) | DRUG | Phase PHASE2 | Migraine | COMPLETED | NCT02472418 |
| Eszopiclone Tablets 3 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02322658 |
| Paricalcitol Capsules, 4 mcg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02322632 |
| Moxifloxacin Tablets 400 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02322619 |
| Panitumumab | DRUG | Phase PHASE4 | Cancer | UNKNOWN | NCT02301962 |
| MabThera | BIOLOGICAL | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT02296775 |
| Rituxan | BIOLOGICAL | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT02296775 |
| DRL_RI | BIOLOGICAL | Phase PHASE1 | Rheumatoid Arthritis | COMPLETED | NCT02296775 |
| Sirolimus | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02296762 |
| Valganciclovir Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02297854 |
| Amlodipine besylate/Atorvastatin calcium | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02295046 |
| Cymbalta® | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02291367 |
| Duloxetine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT02291367 |
| DFN-02 | DRUG | Phase PHASE3 | Acute Migraine | COMPLETED | NCT02279082 |
| Doxorubicin Hydrochloride Liposome Injection | DRUG | Phase PHASE1 | Ovarian Epithelial Cancer Recurrent | COMPLETED | NCT02260544 |
| Pegfilgrastim Form B | BIOLOGICAL | Phase PHASE1 | Pharmacokinetics | UNKNOWN | NCT02205320 |
| Pegfilgrastim Form A | BIOLOGICAL | Phase PHASE1 | Pharmacokinetics | UNKNOWN | NCT02205320 |
| DRL_PG | BIOLOGICAL | Phase PHASE1 | Pharmacokinetics | UNKNOWN | NCT02205320 |
| XP23829 400 mg BID | DRUG | Phase PHASE2 | Psoriasis | COMPLETED | NCT02173301 |
| XP 23829 800 mg QD | DRUG | Phase PHASE2 | Psoriasis | COMPLETED | NCT02173301 |
| XP23829 400 mg QD | DRUG | Phase PHASE2 | Psoriasis | COMPLETED | NCT02173301 |
| omeprazole | DRUG | Phase PHASE4 | GERD | UNKNOWN | NCT02140073 |
| omeprazole+domperidone SR | DRUG | Phase PHASE4 | GERD | UNKNOWN | NCT02140073 |
| saline 0.9% | OTHER | Phase PHASE1 | Head Lice | COMPLETED | NCT02062073 |
| 0.1% sodium lauryl sulfate | OTHER | Phase PHASE1 | Head Lice | COMPLETED | NCT02062073 |
| Saline 0.9% | DRUG | Phase PHASE1 | Head Lice | COMPLETED | NCT02061813 |
| Sodium Lauryl Sulfate | DRUG | Phase PHASE1 | Head Lice | COMPLETED | NCT02061813 |
| Vehicle Lotion | DRUG | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT02097485 |
| Abametapir Lotion 0.74% w/w | DRUG | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT02097485 |
| Ha44 Gel 0.74% w/w | DRUG | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT02010333 |
| Donepezil | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01923558 |
| Ha44 Gel | DRUG | Phase PHASE2 | Head Lice Infestation | COMPLETED | NCT01907490 |
| Fexofenadine Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01888718 |
| DFA-02 Placebo Gel | DRUG | Phase PHASE2 | Surgical Site Infections | COMPLETED | NCT01888367 |
| DFA-02 Antibiotic Gel | DRUG | Phase PHASE2 | Surgical Site Infections | COMPLETED | NCT01888367 |
| Isotretinoin | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01888341 |
| Lubiprostone | DRUG | Phase PHASE3 | Chronic Idiopathic Constipation | COMPLETED | NCT01674530 |
| Montelukast sodium chewable tablets 4mg and 5mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01674517 |
| Montelukast sodium chewable tablets 4 mg and 5 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01674504 |
| Metoprolol Succinate | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01694797 |
| Montelukast sodium | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01691469 |
| Atorvastatin Calcium Tablets, 80 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01645449 |
| Atorvastatin Calcium Tablets, 40 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01645410 |
| Ibandronate sodium | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01627886 |
| Ropinirole | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01627847 |
| Ziprasidone Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01581879 |
| Quetiapine fumarate | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01566487 |
| Metronidazole-DRF2 | DRUG | Phase PHASE2 | Clostridium Difficile Associated Diarrhea | COMPLETED | NCT01559545 |
| Metronidazole-DRF1 | DRUG | Phase PHASE2 | Clostridium Difficile Associated Diarrhea | COMPLETED | NCT01559545 |
| Metronidazole | DRUG | Phase PHASE2 | Clostridium Difficile Associated Diarrhea | COMPLETED | NCT01559545 |
| Moxifloxacin | DRUG | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Moxifloxacin Placebo | DRUG | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Ha44 Placebo | DRUG | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Ha44 | DRUG | Phase PHASE1 | Pediculosis | COMPLETED | NCT01518699 |
| Lamictal® | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01513720 |
| Venlafaxine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01512459 |
| Fluconazole | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01511770 |
| Pepcid | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01511731 |
| Famotidine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01511731 |
| Ondansetron Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01511718 |
| Clopidogrel | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01621763 |
| Levocetirizine DiHCl | DRUG | Phase PHASE1 | Fasting | COMPLETED | NCT01506076 |
| Amlodipine Besylate/Benazepril HCl | DRUG | Phase PHASE1 | Fasting | COMPLETED | NCT01506011 |
| Aricept | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01504516 |
| Donepezil Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01504516 |
| Olanzapine OD Tablets 5 mg | DRUG | Phase PHASE1 | Fed | COMPLETED | NCT01503450 |
| Olanzapine | DRUG | Phase PHASE1 | Fed | COMPLETED | NCT01503424 |
| DFA-02 | DRUG | Phase PHASE1 | Surgical Site Infection | COMPLETED | NCT01496352 |
| Placebo | OTHER | Phase PHASE2 | COVID-19 Prevention | UNKNOWN | NCT04640233 |
| Aprepitant | DRUG | Phase PHASE3 | Chemotherapy Induced Nausea and Vomiting | COMPLETED | NCT01402024 |
| DRL-17822 or placebo | DRUG | Phase PHASE2 | Type II Hyperlipidemia | COMPLETED | NCT01388816 |
| Desloratadine and pseudoephedrine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01506791 |
| Letrozole | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01375452 |
| CIPRO®XR | DRUG | Phase PHASE1 | Fed | COMPLETED | NCT01372358 |
| Reminyl | DRUG | Phase PHASE1 | Fed | COMPLETED | NCT01372306 |
| Group C - Placebo | DRUG | Phase PHASE2 | Pediculosis | COMPLETED | NCT01336647 |
| Group B - High Dose Ha44 Gel 0.74% w/w | DRUG | Phase PHASE2 | Pediculosis | COMPLETED | NCT01336647 |
| Group A - Low-Dose Ha44 0.37% w/w | DRUG | Phase PHASE2 | Pediculosis | COMPLETED | NCT01336647 |
| Desloratadine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01506050 |
| Terbinafine Hydrochloride Tablets, 250 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01286701 |
| Pantoprazole Sodium | DRUG | Phase PHASE1 | FED | COMPLETED | NCT01283932 |
| Mycophenolate Mofetil | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01513057 |
| Zafirlukast | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01283061 |
| Lansoprazole | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01270308 |
| Sumatriptan | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01269281 |
| Sertraline | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01267396 |
| Prilosec® 40 mg | DEVICE | Phase PHASE1 | Healthy | COMPLETED | NCT01170182 |
| Prilosec | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01170169 |
| Simvastatin | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01167933 |
| Fluoxetine Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01166100 |
| Relafen | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01164826 |
| Nabumetone | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01164826 |
| Mavik | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01164800 |
| Trandolapril | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01164800 |
| Altace | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01164774 |
| Ramipril | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01164774 |
| Zonegran | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01161979 |
| Zonisamide | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01161979 |
| Axid | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01161940 |
| Nizatidine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01161940 |
| Meloxicam | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01161147 |
| Glucophage | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01160068 |
| Metformin | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01160068 |
| Nateglinide | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01160029 |
| Anastrozole | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01155960 |
| Risperidone Orally Disintegrating Tablets | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01155934 |
| Amlodipine Besylate / Benazepril Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01155908 |
| Citalopram Hydrobromide | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01149980 |
| Ibuprofen | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01149954 |
| Pravastatin Sodium | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01146106 |
| Rivastigmine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01146067 |
| Valacyclovir Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01136538 |
| Alendronate Sodium Tablets, 70 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01133496 |
| Fexofenadine HCl + Pseudoephedrine HCl | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01133483 |
| Finasteride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01264302 |
| Primidone | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01132040 |
| Tacrolimus Capsules | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01132027 |
| Lamotrigine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01888757 |
| Amlodipine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01131936 |
| Levetiracetam | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01132352 |
| Ibuprofen + Pseudoephedrine Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01132222 |
| Naproxen Sodium & Pseudoephedrine HCl | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01131767 |
| Ranitidine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01131702 |
| Fexofenadine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01066767 |
| Tizanidine | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01146028 |
| Risperidone | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01064271 |
| Carvedilol | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01064180 |
| Cetirizine Hydrochloride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01064115 |
| Usual cardiovascular medications | DRUG | Phase PHASE3 | Cardiovascular Diseases | COMPLETED | NCT01057537 |
| polypill | DRUG | Phase PHASE3 | Cardiovascular Diseases | COMPLETED | NCT01057537 |
| Divalproex Sodium | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01581788 |
| Glimepiride tablets 1 mg | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01053689 |
| Ibuprofen and Diphenhydramine Citrate | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01053338 |
| Glimepiride | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01052909 |
| Naproxen Sodium | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01052792 |
| Naproxen sodium | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01052129 |
| Omeprazole | DRUG | Phase PHASE1 | Healthy | COMPLETED | NCT01170182 |
Total products: 526